Rezultati pretraživanja
  1. 13. kol 2019.

    "Technosphere Tech is extraordinary...Tyvaso market will Triple." -Wedbush PacGrow Health Conference

  2. 24. tra 2019.

    A new study has identified a region in the genome that could contribute to increased susceptibility to suffering among carriers of a mutation in the gene BMPR2, which is responsible for the heritable form of the disease

  3. 31. lis 2018.

    Straight from United Therapeutics 10-Q: Compares TreT & Substantial Lifestyle benefits compared to TYVASO (their own product).

  4. 30. lis 2019.
  5. 11. ruj 2019.
  6. 27. ožu 2018.
  7. new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. .

  8. 3. velj

    announces sotatercept achieved primary and secondary endpoints in the PULSAR trial

  9. 1. velj
  10. 30. sij

    Reliability and responsiveness of incremental shuttle walk test to estimate exercise capacity in patients with pulmonary arterial hypertension R. Ishrat, A. Mujaddadi, M.S. Ali, D. Talwar, M.E. Hussain

  11. 29. sij

    This drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in , some now see blockbuster potential. shares shot up 50% Tues.

  12. new publication: Safety of riociguat for the treatment of pulmonary arterial hypertension: Final data cut from the expert registry. .

  13. 11. pro 2019.

    Cardiologist Dr. Raymond Benza discusses and once weekly VIP analogue PB1046 currently in clinical trials for adults with . Listen to the podcast here.

  14. 11. pro 2019.

    Study suggests mechanical basis for using & end-diastolic volume ratio as clinical index for delineating disease severity, estimating RV free wall contractility in patients

  15. 3. pro 2019.

    Have you visited the on ? Take a look at our archives for some great free content, such as this installation of on :

  16. 15. stu 2019.
  17. 11. stu 2019.

    Tomorrow the will be available to everyone living with . Here’s a sneak peek from ’s Daniela

  18. 8. stu 2019.

    Three days until we unveil the . Here , PH specialist nurse, tells us why the Charter is important

  19. promotes the development of and right ventricular failure. Learn more about ADAMTS8 as a possible novel therapeutic target in a study from

  20. 17. lis 2019.

    mtROS-induced ca2+ entry via TRPV4 regulates mitochondrial morphology in lung microvascular endothelial cells. Read more here in AJP-Lung:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.